BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 30547437)

  • 1. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
    Su EW
    Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconciling multiple connectivity scores for drug repurposing.
    Samart K; Tuyishime P; Krishnan A; Ravi J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational functional genomics-based approaches in analgesic drug discovery and repurposing.
    Lippmann C; Kringel D; Ultsch A; Lötsch J
    Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery.
    Wei Z; Zhu S; Chen X; Zhu C; Duan B; Liu Q
    Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):1028-1036. PubMed ID: 36182102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
    Sun P; Guo J; Winnenburg R; Baumbach J
    Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
    Lötsch J; Kringel D
    Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging Big Data to Transform Drug Discovery.
    Glicksberg BS; Li L; Chen R; Dudley J; Chen B
    Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel drug repurposing approach for non-small cell lung cancer using deep learning.
    Li B; Dai C; Wang L; Deng H; Li Y; Guan Z; Ni H
    PLoS One; 2020; 15(6):e0233112. PubMed ID: 32525938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
    O'Reilly PG; Wen Q; Bankhead P; Dunne PD; McArt DG; McPherson S; Hamilton PW; Mills KI; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):198. PubMed ID: 27143038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.
    He H; Duo H; Hao Y; Zhang X; Zhou X; Zeng Y; Li Y; Li B
    Comput Biol Med; 2023 Mar; 155():106671. PubMed ID: 36805225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.